UPI.com |
FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes …
FDA.gov The U.S. Food and Drug Administration today expanded the approved use of Dexcom's G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years … FDA Approval of Dexcom's Non-Adjunctive Indication Triggers a New Era in Diabetes ManagementBusiness Wire (press release) FDA OKs diabetes device that may replace fingerstick testsUPI.com all 10 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.